Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity.

Metidji A, Omenetti S, Crotta S, Li Y, Nye E, Ross E, Li V, Maradana MR, Schiering C, Stockinger B.

Immunity. 2018 Aug 21;49(2):353-362.e5. doi: 10.1016/j.immuni.2018.07.010. Epub 2018 Aug 14.

2.

Cytochrome P4501-inhibiting chemicals amplify aryl hydrocarbon receptor activation and IL-22 production in T helper 17 cells.

Schiering C, Vonk A, Das S, Stockinger B, Wincent E.

Biochem Pharmacol. 2018 May;151:47-58. doi: 10.1016/j.bcp.2018.02.031. Epub 2018 Mar 1.

3.

Feedback control of AHR signalling regulates intestinal immunity.

Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, Stockinger B.

Nature. 2017 Feb 9;542(7640):242-245. doi: 10.1038/nature21080. Epub 2017 Feb 1.

4.

T-bet is a key modulator of IL-23-driven pathogenic CD4(+) T cell responses in the intestine.

Krausgruber T, Schiering C, Adelmann K, Harrison OJ, Chomka A, Pearson C, Ahern PP, Shale M, Oukka M, Powrie F.

Nat Commun. 2016 May 19;7:11627. doi: 10.1038/ncomms11627.

5.

Defining the microbial transcriptional response to colitis through integrated host and microbiome profiling.

Ilott NE, Bollrath J, Danne C, Schiering C, Shale M, Adelmann K, Krausgruber T, Heger A, Sims D, Powrie F.

ISME J. 2016 Oct;10(10):2389-404. doi: 10.1038/ismej.2016.40. Epub 2016 Mar 22.

6.

Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis.

Griseri T, Arnold IC, Pearson C, Krausgruber T, Schiering C, Franchini F, Schulthess J, McKenzie BS, Crocker PR, Powrie F.

Immunity. 2015 Jul 21;43(1):187-99. doi: 10.1016/j.immuni.2015.07.008.

7.

Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3⁺ Treg cell function in the intestine.

Harrison OJ, Srinivasan N, Pott J, Schiering C, Krausgruber T, Ilott NE, Maloy KJ.

Mucosal Immunol. 2015 Nov;8(6):1226-36. doi: 10.1038/mi.2015.13. Epub 2015 Mar 4.

8.

The alarmin IL-33 promotes regulatory T-cell function in the intestine.

Schiering C, Krausgruber T, Chomka A, Fröhlich A, Adelmann K, Wohlfert EA, Pott J, Griseri T, Bollrath J, Hegazy AN, Harrison OJ, Owens BMJ, Löhning M, Belkaid Y, Fallon PG, Powrie F.

Nature. 2014 Sep 25;513(7519):564-568. doi: 10.1038/nature13577. Epub 2014 Jul 16.

9.

Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2.

Knosp CA, Schiering C, Spence S, Carroll HP, Nel HJ, Osbourn M, Jackson R, Lyubomska O, Malissen B, Ingram R, Fitzgerald DC, Powrie F, Fallon PG, Johnston JA, Kissenpfennig A.

J Immunol. 2013 Apr 1;190(7):3235-45. doi: 10.4049/jimmunol.1201396. Epub 2013 Mar 1.

10.

CD4(+) T-cell subsets in intestinal inflammation.

Shale M, Schiering C, Powrie F.

Immunol Rev. 2013 Mar;252(1):164-82. doi: 10.1111/imr.12039. Review.

11.

Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation.

Griseri T, McKenzie BS, Schiering C, Powrie F.

Immunity. 2012 Dec 14;37(6):1116-29. doi: 10.1016/j.immuni.2012.08.025. Epub 2012 Nov 29.

12.

IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells.

Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, Powrie F, Maloy KJ.

J Exp Med. 2012 Aug 27;209(9):1595-609. doi: 10.1084/jem.20111453. Epub 2012 Aug 13.

13.

Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice.

Hansell CA, Schiering C, Kinstrie R, Ford L, Bordon Y, McInnes IB, Goodyear CS, Nibbs RJ.

Blood. 2011 May 19;117(20):5413-24. doi: 10.1182/blood-2010-11-317115. Epub 2011 Mar 30.

14.

Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ, Powrie F.

Immunity. 2010 Aug 27;33(2):279-88. doi: 10.1016/j.immuni.2010.08.010. Erratum in: Immunity. 2011 Mar 25;34(3):448.

15.

Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo.

Schiering C, Guarnerio J, Basso V, Muzio L, Mondino A.

Cancer Res. 2010 Aug 1;70(15):6161-70. doi: 10.1158/0008-5472.CAN-09-4398. Epub 2010 Jul 14.

16.

Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccination.

Zimmermann VS, Casati A, Schiering C, Caserta S, Hess Michelini R, Basso V, Mondino A.

J Immunol. 2007 Sep 1;179(5):2899-909.

Supplemental Content

Loading ...
Support Center